Epernicus: Michael E Budiman, Ph.D.

Michael E Budiman, Ph.D.

Position:
Field Application Scientist

GE Healthcare (Little Chalfont, United Kingdom)
Degrees:

Ph.D., Chemistry, Wake Forest University (Winston-Salem, NC)
Past Advisors:

Donna M. Driscoll (as Post Doctoral Fellow)

Rebecca W. Alexander (as Graduate Student - Ph.D.)

Ulrich Bierbach (as Graduate Student - Ph.D.)
Research:

Communities:

Michael Budiman's Genealogy

The Adobe Flash Player plugin (version 8) is required to view the genealogy tree.
Download the plugin here.

Michael Budiman's Publications (7)

Identification of a signature motif for the eIF4a3-SECIS interaction.
Budiman ME, Bubenik JL, Driscoll DM

Nucleic acids research. 2011 Sep 1;39(17):7730-9
Nucleolin binds to a subset of selenoprotein mRNAs and regulates their expression.
Miniard AC, Middleton LM, Budiman ME, Gerber CA, Driscoll DM

Nucleic acids research. 2010 Aug;38(14):4807-20
Eukaryotic initiation factor 4a3 is a selenium-regulated RNA-binding protein that selectively inhibits selenocysteine incorporation.
Budiman ME, Bubenik JL, Miniard AC, Middleton LM, Gerber CA, Cash A, Driscoll DM

Molecular cell. 2009 Aug 28;35(4):479-89
Known turnover and translation regulatory RNA-binding proteins interact with the 3' UTR of SECIS-binding protein 2.
Bubenik JL, Ladd AN, Gerber CA, Budiman ME, Driscoll DM

RNA biology. 2009 Jan-Mar;6(1):73-83
Using molecular dynamics to map interaction networks in an aminoacyl-tRNA synthetase.
Budiman ME, Knaggs MH, Fetrow JS, Alexander RW

Proteins. 2007 Aug 15;68(3):670-89
DNA minor groove adducts formed by a platinum-acridine conjugate inhibit association of tata-binding protein with its cognate sequence.
Budiman ME, Bierbach U, Alexander RW

Biochemistry. 2005 Aug 23;44(33):11262-8
Unique base-step recognition by a platinum-acridinylthiourea conjugate leads to a DNA damage profile complementary to that of the anticancer drug cisplatin.
Budiman ME, Alexander RW, Bierbach U

Biochemistry. 2004 Jul 6;43(26):8560-7

Join Epernicus (membership is free)

Epernicus is open to current and former research scientists.

Already a member?
Sign in to view Michael's full profile.